SCHEMBL23085539

SCHEMBL23085539

CC#Cc1cccc(C#N)n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOS2 Q07890 1/20 0.40
CTSK P43235 1/20 0.39
CTSS P25774 1/20 0.38
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
ALDH1A1 P00352 1/20 0.37
TP53 P04637 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
PKM P14618 1/20 0.37
HPGD P15428 1/20 0.37
ALOX15 P16050 1/20 0.37
CYP2C19 P33261 1/20 0.37
THPO P40225 1/20 0.37
GRM5 P41594 1/20 0.37
RAB9A P51151 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5742391 0.89 GRM5 (0.43) KDM4EMEN1NPC1ALDH1A1TP53
SCHEMBL995983 0.83 SOS2 (0.50) SOS2CTSKCTSSKDM4EALDH1A1
SCHEMBL24618603 0.81 SOS2 (0.39) SOS2CTSKCTSSKDM4EMEN1
SCHEMBL22846483 0.78 GRM5 (0.37) KDM4EMEN1NPC1ALDH1A1TP53
SCHEMBL26178688 0.78 GRM5 (0.37) KDM4EMEN1NPC1ALDH1A1TP53
SCHEMBL26381449 0.78 CTSK (0.39) SOS2CTSKCTSSKDM4EMEN1
SCHEMBL23075939 0.76 GRM5 (0.62) KDM4EMEN1NPC1ALDH1A1TP53
SCHEMBL9949090 0.74 GRM5 (0.37) KDM4EMEN1NPC1ALDH1A1TP53
SCHEMBL9137033 0.74 GRM5 (0.37) KDM4EMEN1NPC1ALDH1A1TP53
SCHEMBL17039219 0.74 NOS3 (0.46) KDM4EMEN1NPC1ALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021046407-A1 RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME RIGEL PHARMACEUTICALS, INC. (US) 2021-03-11 WO disclosed